Far Eastern Biotech Announces Endorsement Guarantee to Subsidiary Reaches Threshold under Paragraph 4, Article 25, Clause 1 of the Handling Principles for Loans and Endorsement Guarantees by Publicly Issued Companies

1. Event Date: 115/06/18

2. Endorsed/ Guaranteed Party: (1) Company Name: Bora Pharmaceuticals Inc. (2) Relationship with Guarantee-Providing Company: Indirect wholly-owned subsidiary (100% ownership) of the Company (3) Guarantee Limit (in thousand NT$): 72,844,305 (4) Previous Guarantee Balance (in thousand NT$): 0 (5) Amount of New Guarantee This Time (in thousand NT$): 947,400 (6) Guarantee Balance as of Event Date (in thousand NT$): 947,400 (7) Actual Amount Drawn by Guaranteed Company (in thousand NT$): 0 (8) Reason for New Guarantee: The Company provided financing guarantee for its subsidiary

3. Collateral Provided by the Guaranteed Company: (1) Description: None (2) Value (in thousand NT$): 0

4. Latest Financial Statement of the Guaranteed Company: (1) Capital (in thousand NT$): 0 (2) Accumulated Profit/Loss (in thousand NT$): 11,795

5. Conditions for Release of Guarantee Liability: (1) Conditions: According to contractual terms (2) Date: According to contractual terms

6. Total Guarantee Limit (in thousand NT$): 72,844,305

7. Total Guarantee Balance as of Event Date (in thousand NT$): 14,727,340

8. Ratio of Guarantee Balance Provided by the Company to the Net Equity in the Latest Financial Statement of the Publicly Issued Company as of Event Date: 101.09

9. Ratio of the Combined Total of Guarantee Balance, Long-Term Investment, and Loan Balance to the Net Equity in the Latest Financial Statement of the Publicly Issued Company as of Event Date: 17.36

10. Other Matters to be Disclosed: None